Tradestie Institutional Equity Comparison Engine
MESO vs MNKD โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
MNKD Overall Edge
MNKD Captures Institutional Edge (4โ0 Pillars ยท 8โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Mannkind Corporation (MNKD) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, MESO trades at N/M Forward P/E with -42.6% operating margin (+390.7% YoY revenue) versus MNKD at 26.2x Forward P/E and -3.4% operating margin (+24.0% YoY). In options structure, MESO sits in UNCLASSIFIED (37th %ile IV; Dealer Gamma Walls on Pro) against MNKD sits in CONSOLIDATION (7th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
MNKD
MESO N/M vs MNKD 26.2x Fwd P/E
Growth & Margin Winner
MNKD
Op Margin -42.6% vs -3.4% ยท YoY +390.7% vs +24.0%
Momentum & Technical Winner
MNKD
1Y -16.4% vs -22.9% ยท 52W Pos 6% vs 39%
Options & Structure Winner
MNKD
UNCLASSIFIED (37th %ile IV) vs CONSOLIDATION (7th %ile IV)
MESO
NASDAQ
Mesoblast Limited American Depositary Shares
Biological Products, (No Diagnostic Substances)
$12.47
-6.03% 1D
Market Cap
$1.7B
1M Return
-6.1%
1Y Return
-16.42%
Forward P/E
N/M
Unified AI Score
34.6 / 100
SELL
Tech 25.0
Fund 40.0
Flow 50.0
Mom 50.0
MNKD
NASDAQ
Mannkind Corporation
Pharmaceutical Preparations
$3.91
-5.33% 1D
Market Cap
$1.3B
1M Return
+28.62%
1Y Return
-22.88%
Forward P/E
26.2x
Unified AI Score
36.1 / 100
SELL
Tech 50.0
Fund 38.0
Flow 72.0
Mom 54.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
MESO -16.42%
MNKD -22.88%
Spread: +6.46 pp (MESO Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
MESO TTM Op. Margin: -42.6%
MNKD TTM Op. Margin: -3.4%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MESO vs MNKD. Trailing 12-month operating profitability (MESO -42.6% vs MNKD -3.4%) and valuation multiples (MESO N/M vs MNKD 26.2x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | MESO | MNKD | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.7B | $1.3B | Larger Scale | MESO |
| Trailing P/E Ratio Valuation | N/M | 32.3x | Lower Multiple | MNKD |
| Forward P/E Ratio Valuation | N/M | 26.2x | Lower Multiple | MNKD |
| Revenue Growth (YoY) Growth | +390.7% | +24.0% | Higher Growth | MESO |
| Operating Margin (TTM) Profitability | -42.6% | -3.4% | Higher Margin | MNKD |
| Net Profit Margin Profitability | -47.8% | -18.1% | Higher Margin | MNKD |
| Return on Equity (ROE) Capital Efficiency | -9.9% | 0.0% | Higher ROE | MNKD |
| 52-Week Range Position Momentum | 6% ($12โ$22) | 39% ($2โ$7) | Stronger Trend | MNKD |
| Beta / 30D Volatility Risk Regime | 1.18ฮฒ ยท 78% Vol | 1.29ฮฒ ยท 48% Vol | Lower Realized Risk | MNKD |
| Unified Institutional Score Composite Signal | 34.6 / 100 (SELL) | 36.1 / 100 (SELL) | Higher Composite | MNKD |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full MESO vs MNKD Buy Guide
MESO
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
37th %ile
IV Regime
Balanced (25thโ60th %ile)
MNKD
CONSOLIDATION
95d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
7th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither MESO nor MNKD registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.